Astria Therapeutics
ATXS
ATXS
26 hedge funds and large institutions have $42.1M invested in Astria Therapeutics in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
41% less capital invested
Capital invested by funds: $70.9M → $42.1M (-$28.7M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
26
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.11M | |
| 2 | +$181K | |
| 3 | +$180K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$96.2K |
| 5 |
Goldman Sachs
New York
|
+$46K |
Top Sellers
| 1 | -$741K | |
| 2 | -$160K | |
| 3 | -$136K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$128K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$123K |